Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition

Abhiram Prasad, Suresh Narayanan, Syed Husain, Feroz Padder, Myron Waclawiw, Neil Epstein, Arshed A. Quyyumi

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background: The aim of this study was to examine whether angiotensin- converting enzyme (ACE) inhibition improves coronary endothelial dysfunction in patients with atherosclerosis and its risk factors and whether this was related to the ACE insertion-deletion (I/D) polymorphism. Methods and Results - In 56 patients with atherosclerosis or its risk factors, we studied endothelium-dependent responses with acetylcholine and endothelium- independent function with sodium nitroprusside, before and after ACE inhibition with enalaprilat. Enalaprilat did not alter either resting Coronary tone or vasodilation with sodium nitroprusside. However, it potentiated the coronary microvascular and epicardial responses with acetylcholine; coronary blood flow increased from 82±7 to 90±8 mL/min (P=0.05) after enalaprilat. Patients with depressed endothelial function (P<0.001) and those with ACE DD or ID genotypes (P=0.002) but not those homozygous for the I allele had the greatest improvement by multivariate analysis. Similarly, acetylcholine-mediated epicardial vasomotion improved in segments that initially constricted (endothelial dysfunction): from -10.1±1% to -1.4±2% (P<0.001) after enalaprilat. No augmentation was observed in segments that dilated (normal endothelial dysfunction) with acetylcholine. Patients with the D allele, hypercholesterolemia, and smokers (all P<0.05) had greater improvement. Conclusions - Acute ACE inhibition improves coronary epicardial and microvascular endothelium-dependent vasomotion in patients with atherosclerosis or its risk factors who have endothelial dysfunction and presence of the D allele.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalCirculation
Volume102
Issue number1
StatePublished - Jul 4 2000
Externally publishedYes

Fingerprint

Enalaprilat
Peptidyl-Dipeptidase A
Acetylcholine
Endothelium
Atherosclerosis
Genes
Alleles
Nitroprusside
Hypercholesterolemia
Vasodilation
Multivariate Analysis
Genotype

Keywords

  • Acetylcholine
  • Angiotensin
  • Atherosclerosis
  • Coronary disease
  • Genes

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Prasad, A., Narayanan, S., Husain, S., Padder, F., Waclawiw, M., Epstein, N., & Quyyumi, A. A. (2000). Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation, 102(1), 35-41.

Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. / Prasad, Abhiram; Narayanan, Suresh; Husain, Syed; Padder, Feroz; Waclawiw, Myron; Epstein, Neil; Quyyumi, Arshed A.

In: Circulation, Vol. 102, No. 1, 04.07.2000, p. 35-41.

Research output: Contribution to journalArticle

Prasad, A, Narayanan, S, Husain, S, Padder, F, Waclawiw, M, Epstein, N & Quyyumi, AA 2000, 'Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition', Circulation, vol. 102, no. 1, pp. 35-41.
Prasad A, Narayanan S, Husain S, Padder F, Waclawiw M, Epstein N et al. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation. 2000 Jul 4;102(1):35-41.
Prasad, Abhiram ; Narayanan, Suresh ; Husain, Syed ; Padder, Feroz ; Waclawiw, Myron ; Epstein, Neil ; Quyyumi, Arshed A. / Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. In: Circulation. 2000 ; Vol. 102, No. 1. pp. 35-41.
@article{1e60efb50a5c42b98cd008f0fd1711b0,
title = "Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition",
abstract = "Background: The aim of this study was to examine whether angiotensin- converting enzyme (ACE) inhibition improves coronary endothelial dysfunction in patients with atherosclerosis and its risk factors and whether this was related to the ACE insertion-deletion (I/D) polymorphism. Methods and Results - In 56 patients with atherosclerosis or its risk factors, we studied endothelium-dependent responses with acetylcholine and endothelium- independent function with sodium nitroprusside, before and after ACE inhibition with enalaprilat. Enalaprilat did not alter either resting Coronary tone or vasodilation with sodium nitroprusside. However, it potentiated the coronary microvascular and epicardial responses with acetylcholine; coronary blood flow increased from 82±7 to 90±8 mL/min (P=0.05) after enalaprilat. Patients with depressed endothelial function (P<0.001) and those with ACE DD or ID genotypes (P=0.002) but not those homozygous for the I allele had the greatest improvement by multivariate analysis. Similarly, acetylcholine-mediated epicardial vasomotion improved in segments that initially constricted (endothelial dysfunction): from -10.1±1{\%} to -1.4±2{\%} (P<0.001) after enalaprilat. No augmentation was observed in segments that dilated (normal endothelial dysfunction) with acetylcholine. Patients with the D allele, hypercholesterolemia, and smokers (all P<0.05) had greater improvement. Conclusions - Acute ACE inhibition improves coronary epicardial and microvascular endothelium-dependent vasomotion in patients with atherosclerosis or its risk factors who have endothelial dysfunction and presence of the D allele.",
keywords = "Acetylcholine, Angiotensin, Atherosclerosis, Coronary disease, Genes",
author = "Abhiram Prasad and Suresh Narayanan and Syed Husain and Feroz Padder and Myron Waclawiw and Neil Epstein and Quyyumi, {Arshed A.}",
year = "2000",
month = "7",
day = "4",
language = "English (US)",
volume = "102",
pages = "35--41",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition

AU - Prasad, Abhiram

AU - Narayanan, Suresh

AU - Husain, Syed

AU - Padder, Feroz

AU - Waclawiw, Myron

AU - Epstein, Neil

AU - Quyyumi, Arshed A.

PY - 2000/7/4

Y1 - 2000/7/4

N2 - Background: The aim of this study was to examine whether angiotensin- converting enzyme (ACE) inhibition improves coronary endothelial dysfunction in patients with atherosclerosis and its risk factors and whether this was related to the ACE insertion-deletion (I/D) polymorphism. Methods and Results - In 56 patients with atherosclerosis or its risk factors, we studied endothelium-dependent responses with acetylcholine and endothelium- independent function with sodium nitroprusside, before and after ACE inhibition with enalaprilat. Enalaprilat did not alter either resting Coronary tone or vasodilation with sodium nitroprusside. However, it potentiated the coronary microvascular and epicardial responses with acetylcholine; coronary blood flow increased from 82±7 to 90±8 mL/min (P=0.05) after enalaprilat. Patients with depressed endothelial function (P<0.001) and those with ACE DD or ID genotypes (P=0.002) but not those homozygous for the I allele had the greatest improvement by multivariate analysis. Similarly, acetylcholine-mediated epicardial vasomotion improved in segments that initially constricted (endothelial dysfunction): from -10.1±1% to -1.4±2% (P<0.001) after enalaprilat. No augmentation was observed in segments that dilated (normal endothelial dysfunction) with acetylcholine. Patients with the D allele, hypercholesterolemia, and smokers (all P<0.05) had greater improvement. Conclusions - Acute ACE inhibition improves coronary epicardial and microvascular endothelium-dependent vasomotion in patients with atherosclerosis or its risk factors who have endothelial dysfunction and presence of the D allele.

AB - Background: The aim of this study was to examine whether angiotensin- converting enzyme (ACE) inhibition improves coronary endothelial dysfunction in patients with atherosclerosis and its risk factors and whether this was related to the ACE insertion-deletion (I/D) polymorphism. Methods and Results - In 56 patients with atherosclerosis or its risk factors, we studied endothelium-dependent responses with acetylcholine and endothelium- independent function with sodium nitroprusside, before and after ACE inhibition with enalaprilat. Enalaprilat did not alter either resting Coronary tone or vasodilation with sodium nitroprusside. However, it potentiated the coronary microvascular and epicardial responses with acetylcholine; coronary blood flow increased from 82±7 to 90±8 mL/min (P=0.05) after enalaprilat. Patients with depressed endothelial function (P<0.001) and those with ACE DD or ID genotypes (P=0.002) but not those homozygous for the I allele had the greatest improvement by multivariate analysis. Similarly, acetylcholine-mediated epicardial vasomotion improved in segments that initially constricted (endothelial dysfunction): from -10.1±1% to -1.4±2% (P<0.001) after enalaprilat. No augmentation was observed in segments that dilated (normal endothelial dysfunction) with acetylcholine. Patients with the D allele, hypercholesterolemia, and smokers (all P<0.05) had greater improvement. Conclusions - Acute ACE inhibition improves coronary epicardial and microvascular endothelium-dependent vasomotion in patients with atherosclerosis or its risk factors who have endothelial dysfunction and presence of the D allele.

KW - Acetylcholine

KW - Angiotensin

KW - Atherosclerosis

KW - Coronary disease

KW - Genes

UR - http://www.scopus.com/inward/record.url?scp=0034604252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034604252&partnerID=8YFLogxK

M3 - Article

C2 - 10880412

AN - SCOPUS:0034604252

VL - 102

SP - 35

EP - 41

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -